An observational study in Coronary Artery Disease, Aneurysms and Coronary Intervention, sponsored by Nanjing First Hospital, Nanjing Medical University. Recruiting at 1 site in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-08-13.
Sponsored by Nanjing First Hospital, Nanjing Medical University · Observational
This study aimed to characterize the progression and risk fators of coronary artery aneurysms, and copmpare the outcomes across different management strategies
This study aim to investigated the progression of coronary artery aneurysms (CAA) assessed by angiography, then compared the effectiveness of different management strategies, and identified risk factors associated with lesion progression and major adverse cardiovascular events.
4,857 studies on the registry are indexed under Coronary Artery Disease; 890 are open to participants now.
This study's planned enrollment of 1,000 is above the median of 320 across 1,687 observational studies indexed under Coronary Artery Disease.
Browse Coronary Artery Disease studies →Nanjing First Hospital, Nanjing Medical University is the lead sponsor of 224 studies on the registry; 110 are open to participants now.
Counted across the registry records on this site, refreshed daily.
patients diagnosed with coronary artery aneurysm
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients with angiographically confirmed coronary artery aneurysms, defined as coronary dilation ≥1.5 times than the adjacent reference vessel diameter,
Progression of coronary artery aneurysm
Progression of coronary artery aneurysm assessed by serial angiography or coronary computed tomography angiography
Time frame: 6-12 months
Plan to share: No — Due to privacy and ethical limitations, the data generated and analyzed in current study are not publicly available but could be obtained from principal investigator upon the approval of ethics committee
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Nanjing First Hospital, Nanjing Medical University →